Haolin Sung | Managing Partner
Chaperone Investment | United States

Phar East 2020 Agenda Day Three @ 14:00

Panel: Attracting early-stage capital: What are VCs looking for in biotech investments in Asia?

Moderator: Jeff Weisel, Corporate Strategy Advisor, Ardion

×

Jeff Weisel / Panel: Attracting early-stage capital: What are VCs looking for in biotech investments in Asia?

Jeff Weisel, Corporate Strategy Advisor,
Ardion

Jeff has more than 20 years' experience working with leading organisations across the life sciences and healthcare value chain in Asia Pacific. His roles have encompassed executive positions in the biopharma industry with Novartis and AbbVie as well as leadership of Big 4 consulting...

CloseMore

Viren Mahurkar, Founder And Chairman, HitchinRock Advisors

×

Viren Mahurkar / Panel: Attracting early-stage capital: What are VCs looking for in biotech investments in Asia?

Viren Mahurkar, Founder And Chairman,
HitchinRock Advisors

Viren Mahurkar, Founder and Chairman at HitchinRock Advisors, specializes in deals, investments and economics in the healthcare sector.  Over the course of his career, Mr Mahurkar has held senior leadership positions in both healthcare and investment banking.  He brings a global...

CloseMore

Haolin Sung, Managing Partner, Chaperone Investment

Rohit Singh, Vice President, Xeraya Capital

×

Rohit Singh / Panel: Attracting early-stage capital: What are VCs looking for in biotech investments in Asia?

Rohit Singh, Vice President,
Xeraya Capital

Rohit Singh, CFA has more than a decade experience in PE/VC investments and front end investment banking. As an investment banker, he has represented clients from Asia, Europe and the US, advising them on cross border acquisitions worth over USD 1 billion and as a VC he has been part of investments ...

CloseMore

Joseph Mocanu, Managing Director, Verge HealthTech Fund

×

Joseph Mocanu / Panel: Attracting early-stage capital: What are VCs looking for in biotech investments in Asia?

Joseph Mocanu, Managing Director,
Verge HealthTech Fund

Joseph is the Managing Partner of Verge HealthTech Fund focusing on early stage healthcare technology companies relevant to emerging markets. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he...

CloseMore